This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Haemodialysis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Haemodialysis is the most common treatment for end-stage renal failure. Blood is shunted through an extracorporeal circulation in which waste products and excess fluid are removed by the physical processes of diffusion and ultrafiltration.

Notes:

  • home haemodialysis (HD) has the best patient outcomes (1,2) and is the most cost-effective of any dialysis modality, but its use has been declining in many countries
    • prevalence of home HD varies from 0 to 58.4 per million population, and varies between countries, more than any other renal replacement therapy (RRT) modality
    • variation cannot be explained by the variation in the use of other RRT modalities, nor by prevalence of diabetic nephropathy, national wealth or population density

  • according to the 19th annual report by the UK Renal Registry (2016), on 31 December 2015 there were 61,256 adults in the UK receiving RRT
    • of these, 53.1% had received a transplant, 41.0% were receiving haemodialysis (21.2% in satellite units, 17.8% in hospitals, 2.0% at home), 2.5% were receiving continuous ambulatory peritoneal dialysis and 3.4% were receiving automated peritoneal dialysis
    • in addition, 769 children and young people under the age of 16 years were receiving RRT
      • most had received a transplant (41% live, 34% deceased), with 13% on haemodialysis and 12% on peritoneal dialysis
    • median age of all people newly requiring RRT was 59.0 years; 22.7% of people were from minority ethnic groups

Reference:

  1. MacGregor MS et al. Home haemodialysis-international trends and variation. Nephrol Dial Transplant. 2006 Jul;21(7):1934-45.
  2. Mowatt G et al. Systematic review of the effectiveness of home versus hospital or satellite unit hemodialysis for people with end-stage renal failure. Int J Technol Assess Health Care. 2004 Summer;20(3):258-68
  3. NICE (October 2018). Renal replacement therapy and conservative management

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.